Bibliography: International Policy Issues

These guidelines provide the rationale, steps, procedures, roles, and responsibilities for the operation of the EU Early Warning System (EMCDDA)

This briefing paper reconstructs the long and troubled process that led to the adoption of this ground-breaking UN System Common Position (TNI)

Despite much speculation and conjecture over potential crossovers between terrorists and the drug trade in Europe, no study has examined the issue. This paper fills this gap by empirically examining such crossovers in the European Union between 2012 and 2017 (EMCDDA)

This paper explains the methodology developed by the EMCDDA for open-source information monitoring in the area of drug markets. Initially designed to support the work of the EU Early Warning System in 2016, the technique has recently been expanded to cover open-source information through a pilot project focusing on data on heroin and cocaine seizures of 100 kg or more for the European market between April 2017 and March 2018 (EMCDDA)

This information brochure has been produced by the EMCDDA to provide answers to the most commonly asked questions on the Reitox network of national focal points and more broadly on national drugs observatories (EMCDDA)

This report identifies five essential conditions needed to create and sustain a healthy life for all: good quality and accessible health services; income security and social protection; decent living conditions; social and human capital and decent work and employment conditions. Policy actions are needed to address all five conditions (WHO)

The profile presents the structure, objectives and working methods of the Serbian national early warning system (EMCDDA)

Presented in five separate parts that divide the wealth of information and analysis contained in the report into individual reader-friendly booklets in which drugs are grouped by their psychopharmacological effect for the first time in the report’s history (UNODC)

This paper provides an overview of established and emerging cannabis products in Europe. For each type of product, major issues in its production, distribution, use and effects on health are detailed. In doing so, the paper seeks to inform a discussion of the new challenges that may emerge in the monitoring of these products and the consequences of their use (EMCDDA)

As can be seen over the past 45 years or so, the potency of the Report has arguably shifted away from the public and more towards influencing opinion within the UN’s central policy-making body on the issue of drugs, the Commission on Narcotic Drugs  (IDPC)